Infantile Severe Myoclonic Epilepsy: Disease Bioinformatics
Epilepsy is defined as a diverse set of neurological disorders characterized by seizures. These seizures occur due to abnormal electrical activity in the brain. Factors that may lead to epilepsy include, but are not limited to, brain trauma, gene mutations, strokes, brain cancer, and extensive drug and alcohol use. Seizures occur due to a large release of glutamate, which causes a spread of excitation throughout the brain, which propagates the electrical signal and can lead to neuronal death. Myoclonic infantile epilepsy is characterized by seizures that contain rapid, jerk-like movements that can affect the face and limbs. Myoclonic seizures occur during wakefulness. In infants, myoclonic seizures can be caused by include brain malformations, inborn errors of metabolism, and neurogenetic disorders. The severity of the seizures can vary, and the severe episodes can lead to the child falling and undergoing violent convulsions. About 50 million people have epilepsy, with 80% of that population located in developing countries. It is possible to control epilepsy with medicine, but many cases may require surgery in order to relieve symptoms.
Infantile Severe Myoclonic Epilepsy Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Infantile Severe Myoclonic Epilepsy below!
For more information on how to use Laverne, please read the How to Guide.
We have 430 products for the study of Infantile Severe Myoclonic Epilepsy that can be applied to Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.